T220. IMPACT OF SECOND-GENERATION ANTIPSYCHOTIC SIDE EFFECTS ON FUNCTIONING FROM A SCHIZOPHRENIA PATIENT PERSPECTIVE: GLOBAL PATIENT CENTERED SURVEY INCLUDING PATIENTS FROM ITALY

por Weiss, Catherine, Rasmussen Meehan, Stine, Lenderking, William R, Shalhoub, Huda, Dias-Barbosa, Carla, Schulz, Andrea, Chen, Justin, Greene, Malik
Publicado 2020

M191. EFFECT OF BREXPIPRAZOLE ON ENGAGEMENT IN PATIENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF THREE STUDIES

por Ismail, Zahinoor, Pedersen, Anne M, Thase, Michael E, Rasmussen Meehan, Stine, Weiss, Catherine, Groes Larsen, Klaus, Chen, Dalei, Nylander, Anna-Greta, Baker, Ross A, McIntyre, Roger
Publicado 2020

Life Engagement Improvement Following Initiation of Brexpiprazole Treatment in Patients with MDD: A Naturalistic, Retrospective Real-World Study

por Wee, Soon Nan, Liman, Christian, Waters, Heidi C, Houle, Christy R, Renteria, Miguel, Mukherjee, Sankha S, Surendran, Subina, Marcovici, Joshua, Brubaker, Malaak, Rasmussen Meehan, Stine, de Jong-Laird, Anne, Rush, A John, Sarkar, Joydeep
Publicado 2023